The expressions of IRF4 and PRDM1 were increased in plasmablasts (27) and, as revealed by microarray analysis, were significantly increased in CD38+CD43+ B cells of both healthy donors and SLE patients (Supplementary Figures 2A and B). Here, CD38 is linked to systemic lupus erythematosus.